Therapeutic management of primary central nervous system lymphoma : Lessons from prospective trialsFERRERI, A. J. M; RENI, M; VILLA, E et al.Annals of oncology. 2000, Vol 11, Num 8, pp 927-937, issn 0923-7534Article

Second-line treatment for primary central nervous system lymphomaRENI, M; FERRERI, A. J. M; VILLA, E et al.British journal of cancer. 1999, Vol 79, Num 3-4, pp 530-534, issn 0007-0920Article

Primary central nervous system lymphoma in immunocompetent patientsFERRERI, A. J. M; RENI, M; VILLA, E et al.Cancer treatment reviews. 1995, Vol 21, Num 5, pp 415-446, issn 0305-7372Article

The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the boneGOVI, S; CHRISTIE, D; TAYLOR, E et al.Annals of oncology. 2014, Vol 25, Num 1, pp 176-181, issn 0923-7534, 6 p.Article

Primary intraocular lymphoma : an International Primary Central Nervous System Lymphoma Collaborative Group ReportGRIMM, S. A; PULIDO, J. S; NEUWELT, E. A et al.Annals of oncology. 2007, Vol 18, Num 11, pp 1851-1855, issn 0923-7534, 5 p.Article

Diffuse large-cell lymphoma of the testisTONDINI, C; FERRERI, A. J. M; SIRACUSANO, L et al.Journal of clinical oncology. 1999, Vol 17, Num 9, pp 2854-2858, issn 0732-183XArticle

Low sensitivity of computed tomography in the staging of gastric lymphomas of mucosa-associated lymphoid tissue: Impact on prospective trials and ordinary clinical practiceFERRERI, A. J. M; PONZONI, M; CORDIO, S et al.American journal of clinical oncology. 1998, Vol 21, Num 6, pp 614-616, issn 0277-3732Article

Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute ExperienceTONDINI, C; GIARDINI, R; BONADONNA, G et al.Annals of oncology. 1993, Vol 4, Num 10, pp 831-837, issn 0923-7534Article

The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLLO5 trial of the Fondazione Italiana Linfomi (FIL)LUMINARI, S; BIASOLI, I; GALLAMINI, A et al.Annals of oncology. 2014, Vol 25, Num 2, pp 442-447, issn 0923-7534, 6 p.Article

Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexaFERRERI, A. J. M; VIALE, E; PONZONI, M et al.Annals of oncology. 2006, Vol 17, Num 5, pp 769-772, issn 0923-7534, 4 p.Article

Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaFERRERI, A. J. M; CAMPO, E; ERIKSSON, M et al.Annals of oncology. 2004, Vol 15, Num 8, pp 1215-1221, issn 0923-7534, 7 p.Article

Technique de réplétion-corrosion pour l'étude de l'os temporal et son contenu = Corrosion cast technique to study the temporal boneFERRERI, A. J. M; CASTANON, M. H. D; TERAGNI, E et al.Bulletin de l'Association des anatomistes. 1994, Vol 78, Num 242, pp 9-13, issn 0376-6160Article

Infectious agents and lymphoma development : molecular and clinical aspectsFERRERI, A. J. M; ERNBERG, I; COPIE-BERGMAN, C et al.Journal of internal medicine. 2009, Vol 265, Num 4, pp 421-438, issn 0954-6820, 18 p.Article

Ocular adnexal MALT lymphoma : an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapyFERRERI, A. J. M; DOLCETTI, R; CAVALLI, F et al.Annals of oncology. 2008, Vol 19, Num 5, pp 835-846, issn 0923-7534, 12 p.Article

Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomasPONZONI, M; BERGER, F; CERATI, M et al.British journal of haematology. 2007, Vol 138, Num 3, pp 316-323, issn 0007-1048, 8 p.Article

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomasFERRERI, A. J. M; GUERRA, E; FERRARESE, F et al.British journal of cancer. 2004, Vol 90, Num 2, pp 353-358, issn 0007-0920, 6 p.Article

A multicenter study of treatment of primary CNS lymphomaFERRERI, A. J. M; RENI, M; BORISCH, B et al.Neurology. 2002, Vol 58, Num 10, pp 1513-1520, issn 0028-3878Article

Role of dose intensity in conservative treatment of anal canal carcinoma : Report of 35 casesCERESOLI, G. L; FERRERI, A. J. M; CORDIO, S et al.Oncology. 1998, Vol 55, Num 6, pp 525-532, issn 0030-2414Article

Primary brain lymphomas in patients with a prior or concomitant malignancyRENI, M; FERRERI, A. J. M; ZOLDAN, M. C et al.Journal of neuro-oncology. 1997, Vol 32, Num 2, pp 135-142, issn 0167-594XArticle

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana LinfomiARCAINI, L; VALLISA, D; TUCCI, A et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1404-1410, issn 0923-7534, 7 p.Article

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionMIAN, M; SCANDURRA, M; BALDINI, L et al.Annals of oncology. 2012, Vol 23, Num 3, pp 729-735, issn 0923-7534, 7 p.Article

The prevalence and clinical implications of c-kit expression in plasma cell myelomaPRUNERI, G; PONZONI, M; AGAZZI, A et al.Histopathology. 2006, Vol 48, Num 5, pp 529-535, issn 0309-0167, 7 p.Article

Therapeutic management of stage I-II high-grade primary gastric lymphomasFERRERI, A. J. M; CORDIO, S; PARO, S et al.Oncology. 1999, Vol 56, Num 4, pp 274-282, issn 0030-2414Article

Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesionFERRERI, A. J. M; RENI, M; ZOLDAN, M. C et al.Cancer. 1996, Vol 77, Num 5, pp 827-833, issn 0008-543XArticle

Prevalence of chlamydial infection in a series of 108 primary cutaneous tymphomasFERRERI, A. J. M; PONZONI, M; DOLCETTI, R et al.British journal of dermatology (1951). 2012, Vol 166, Num 5, pp 1121-1123, issn 0007-0963, 3 p.Article